Changes in serum somatomedin and growth hormone concentrations after 3 weeks oestrogen substitution in post-menopausal women; a pilot study

1984 ◽  
Vol 106 (4) ◽  
pp. 527-531 ◽  
Author(s):  
S. A. Duursma ◽  
J. W. J. Bijlsma ◽  
H. C. Van Paassen ◽  
S. C. van Buul-Offers ◽  
A. Skottner-Lundin
Keyword(s):  
Growth Hormone ◽  
Pilot Study ◽  
Serum Levels ◽  
Preventive Effect ◽  
Positive Role ◽  
Menopausal Women ◽  
The Mean ◽  
Post Menopausal ◽  
Serum Gh

Abstract. Oestrogens have a preventive effect on bone loss in post-menopausal women; however, little is known about their mechanism of action. The aim of this study was to investigate the changes in somatomedins (SM) and growth hormone (GH) concentrations in serum in postmenopausal women after 3 weeks of substitution with 20 μg ethinyloestradiol. A significant decrease was observed in the mean serum levels of SM. measured by bioassay (0.66 ± 0.07 vs 0.38 ± 0.07. P < 0.01), radioimmunoassay (0.62 ± 0.08 vs 0.34 ± 0.03, P < 0.01) and radioreceptorassav (1.14 ± 0.11 vs 0.90 ± 0.09, P < 0.01). The mean serum GH concentration increased (9.4 ± 3.2 vs 16.5 ± 4.6, P < 0.01). A positive role of SM and GH in the changes of bone metabolism after oestrogen substitution in post-menopausal women is discussed.

SERUM THYROTROPHIN, PROLACTIN AND GROWTH HORMONE, RESPONSE TO TRH DURING OESTROGEN TREATMENT

1977 ◽  
Vol 84 (1) ◽  
pp. 23-35 ◽  
Author(s):  
E. Rutlin ◽  
E. Haug ◽  
P. A. Torjesen
Keyword(s):  
Growth Hormone ◽  
Human Subjects ◽  
Serum Levels ◽  
Normal Male ◽  
Oestrogen Treatment ◽  
Thyrotrophin Releasing Hormone ◽  
Basal Serum ◽  
Menopausal Women ◽  
Menstruating Women ◽  
Post Menopausal

ABSTRACT The serum levels of thyrotrophin (TSH), prolactin (PRL) and growth hormone (GH) and the response of these hormones to 500 μg thyrotrophin-releasing hormone (TRH) iv were studied in menstruating women. in post-menopausal women before and after 2 mg oestradiol valerate for 5 consecutive days, and in men on long term oestrogen treatment. Oestrogen treatment had no effect on basal serum TSH levels, which were within the normal range in all groups. The TSH response to TRH was not different in menstruating and post-menopausal women and was not changed in the latter group after oestrogen treatment. In men treated chronically with oestrogens, the TSH response to TRH was similar to that found in normal male subjects. There was no difference in basal levels of serum PRL between males and menstruating females. In the post-menopausal women, however, basal levels of serum PRL was significantly decreased, but rose during oestrogen treatment to serum levels normally found in menstruating women. In the oestrogen treated males basal serum PRL levels were significantly higher than in untreated men. The PRL response to TRH was significantly greater in females than in males, but in the oestrogen treated males the PRL response to TRH was greatly increased and almost of the same magnitude as the response in females. There was no difference in PRL response between menstruating and post-menopausal women, and oestrogen treatment of the latter group had no significant effect on the PRL response. Basal levels of serum GH did not differ between the groups. In the group of 9 post-menopausal women one subject showed a small GH response to TRH prior to oestrogen treatment, while 7 subjects showed GH responses to TRH after oestrogen treatment. In the group of 5 chronically oestrogen treated men, 2 subjects had increased serum levels of GH after TRH. Thus our data show that oestrogen administration may induce PRL release in human subjects, while oestrogens seem to play a far less important role in the regulation of GH and TSH secretion.

The incidence and pathogenesis of hyperlipidaemia in 16 consecutive acromegalic patients

1982 ◽  
Vol 100 (3) ◽  
pp. 358-362 ◽  
Author(s):  
Ryoyu Takeda ◽  
Ryozo Tatami ◽  
Kosei Ueda ◽  
Hosaku Sagara ◽  
Hajime Nakabayashi ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Serum Lipids ◽  
High Growth ◽  
Serum Levels ◽  
Inhibitory Effect ◽  
Type Iii ◽  
The Mean ◽  
Type V ◽  
Serum Gh ◽  
Normal Controls

Abstract. Serum lipids were analyzed in 16 patients with active acromegaly. Of these 62.5% had hyperlipidaemia defined as exceeding the 90% fiducial limits of normal controls. The mean serum cholesterol (5.50 mmol/l) and triglyceride (4.09 mmol/1) levels of the patients were significantly higher than those of age-matched normal controls. Type V hyperlipoproteinaemia was observed in two cases and type III hyperlipoproteinaemia in one. There was no difference in the incidence of diabetes between the normolipidaemic (n = 6) and hyperlipidaemic (n = 10) groups. Serum levels of growth hormone in hypercholestelaemic patients (n = 3) were significantly higher than those of normolipidaemic patients and combined hyperlipidaemic patients (n = 5) tended to have higher levels of growth hormone than normolipidaemic patients. In cases developing type III or type V hyperlipoproteinaemia, the activity of hepatic triglyceride lipase or lipoprotein lipase was decreased, but it increased when serum GH levels fell after therapy for acromegaly. It is suggested that 1) growth hormone may play some role on the pathogenesis of hyperlipidaemia associated with acromegaly, and 2) growth hormone has an inhibitory effect on H-TGL and LPL, and so hyperlipoproteinaemia in some cases of acromegaly might be caused by low H-TGL or LPL activity resulting from high growth hormone levels.

Effects of calcifediol versus cholecalciferol on 25(OH)D3 serum levels, appendicular muscle strength, and physical performance in post-menopausal women

2016 ◽  
Author(s):  
Antimo Moretti ◽  
Sire Alessandro de ◽  
Dario Calafiore ◽  
Raffaele Gimigliano ◽  
Francesca Gimigliano ◽  
...  
Keyword(s):  
Muscle Strength ◽  
Physical Performance ◽  
Serum Levels ◽  
Menopausal Women ◽  
Post Menopausal

scholarly journals Evaluation of Serum Immunoglobulins (IgG, IgA, IgM) and Circulating Immune Complexes in Oral Precancer and Cancer Patients

2021 ◽  
Author(s):  
Pooja Madki ◽  
Mandya Lakshman Avinash Tejasvi ◽  
Geetha Paramkusam ◽  
Ruheena Khan ◽  
Shilpa J.
Keyword(s):  
Oral Cancer ◽  
Immune Complexes ◽  
Serum Levels ◽  
Circulating Immune Complexes ◽  
Oral Cancers ◽  
Cancer Group ◽  
Oral Precancer ◽  
Serum Iga ◽  
The Mean

Abstract Objectives The aim of the present study is to evaluate the role of immunoglobulins (IgA, IgG, and IgM) and circulating immune complexes (CIC) as tumor marker in oral cancer and precancer patients. Materials and Methods The present study was performed on 45 individuals subdivided into three groups, that is, oral precancer, oral cancer and healthy individuals, and levels of immunoglobulins, and CIC was estimated by turbidometry and ELISA method. Results In the present study, the mean serum IgA levels in oral precancer were 161.00 ( ±  118.02) mg/dL, oral cancers were 270.67 ( ±  171.44) mg/dL, and controls were 133.73 ( ±  101.31) mg/dL. Mean serum levels of IgG in oral precancer were 1,430.87 ( ±  316) mg/dL, oral cancers were 1,234.27 ( ±  365.42) mg/dL, and controls were 593.87 ( ±  323.06) mg/dL. Conclusion We found that the levels of serum IgG and IgA were elevated consistently in precancer and cancer group, and Serum IgM levels were increased only in precancer. Also, significant increase in serum CIC levels were seen in oral precancer and cancer group on comparison with control.

Steroid Formation in Osteoblast-Like Cells

1998 ◽  
Vol 26 (1) ◽  
pp. 1-12 ◽  
Author(s):  
H Saito ◽  
T Yanaihara
Keyword(s):  
Cell Lines ◽  
Messenger Ribonucleic Acid ◽  
Steroid Sulphatase ◽  
Menopausal Women ◽  
Hormonal Action ◽  
Polymerase Chain ◽  
Post Menopausal ◽  
Receptor Mrnas

For preventing the reduction of bone mass in post-menopausal women, oestrogen replacement is known to be useful and the importance of sex steroids in bone metabolism in both sexes is well established. The presence of steroid-converting-enzyme activities in various osteoblast and osteoblast-like cells has been demonstrated using in vitro culture systems. In the present study, we assessed the expression of messenger ribonucleic acid (mRNA) for aromatase, steroid sulphatase, 5α-reductase, 17β-hydroxysteroid dehydrogenase (17β-HSD) and 3β-HSD by reverse transcription-polymerase chain reaction in the human osteoblast-like cell lines, MG 63 and HOS. Oestrogen, androgen and progesterone receptor mRNAs were also measured. Expression of mRNA for these enzymes and receptors was found in both cell lines without induction. From these and previous findings, we conclude that osteoblast-like cells have the capacity to form biologically potent oestrogens and androgens from peripheral circulating steroids. This may indicate an important role of bone in facilitating hormonal action.

The effects of bovine somatotropin on hair follicle activity and cashmere fibre growth in goats

1999 ◽  
Vol 50 (8) ◽  
pp. 1365 ◽  
Author(s):  
D. Villar ◽  
S. M. Rhind ◽  
S. R. McMillen ◽  
P. Dicks
Keyword(s):  
Growth Hormone ◽  
Growth Factor ◽  
Hair Follicle ◽  
Bovine Somatotropin ◽  
Igf I ◽  
Fibre Growth ◽  
Cashmere Goats ◽  
The Mean ◽  
Secondary Fibre

The aim of this study was to determine the role of circulating growth hormone (GH) profiles in the cessation of secondary hair follicle activity and secondary fibre growth in goats during autumn/winter and to determine whether it is possible to extend the period of growth of this fibre by artificially increasing circulating concentrations of this hormone. Nine cashmere goats were each injected, weekly, with 50 mg of bovine somatotropin (bST; treated) in carrier oil, for a period of 5 months between late August and late January. Goats of a second group of 9 animals were injected with sesame oil and served as controls. Treated goats had significantly higher circulating concentrations of growth hormone (P< 0.001), insulin (P< 0.01), thyroxine (P< 0.001), and insulin-like growth factor-I (IGF-I; P< 0.001). Secondary fibre growth rate and liveweight gains were significantly (P< 0.05) higher in treated than control goats. The proportion of active secondary follicles was positively associated with circulating IGF- I concentrations in treated but not control goats. Follicle activity was not related to the profiles of any of the other hormones measured. The mean date of cessation of secondary fibre growth was not affected by treatment. It is concluded that treatment with bST stimulated the rate of secondary fibre growth but did not delay the time of cessation of this growth or the decline in follicle activity. It is further concluded that circulating hormone profiles do not directly control follicle activity and secondary fibre growth and moult and that their effects probably involve changes within the skin and/or hair follicle, possibly in hormone receptor populations, deiodinase enzyme activity, or growth factor synthesis.

THE MEANING OF URINARY INCONTINENCE TO POST MENOPAUSAL WOMEN: A QUALITATIVE PILOT STUDY IN IRAN

Maturitas ◽  
2009 ◽  
Vol 63 ◽  
pp. S117
Author(s):  
M. Pakgohar ◽  
T.A. Hamid ◽  
H. Mohed Riji ◽  
R. Ibrahim ◽  
M. Vahid Dastjerdi
Keyword(s):  
Urinary Incontinence ◽  
Pilot Study ◽  
Menopausal Women ◽  
Post Menopausal
Sign in / Sign up

Export Citation Format

Share Document